HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $288,384 | -84.0% | 3,485 | -86.3% | 0.02% | -82.2% |
| Q3 2021 | $1,801,000 | -6.2% | 25,517 | -11.5% | 0.10% | -1.9% |
| Q2 2021 | $1,921,000 | +17.3% | 28,833 | +95.6% | 0.10% | +10.8% |
| Q1 2021 | $1,637,000 | +10.7% | 14,743 | +18.4% | 0.09% | -13.1% |
| Q4 2020 | $1,479,000 | -44.4% | 12,453 | -59.2% | 0.11% | +24.4% |
| Q3 2020 | $2,660,000 | +6.5% | 30,486 | +9.3% | 0.09% | +34.4% |
| Q2 2020 | $2,498,000 | -19.8% | 27,889 | -10.8% | 0.06% | -22.0% |
| Q1 2020 | $3,115,000 | +26.9% | 31,256 | +46.3% | 0.08% | +141.2% |
| Q4 2019 | $2,455,000 | -36.6% | 21,364 | -30.4% | 0.03% | -26.1% |
| Q3 2019 | $3,875,000 | +5.5% | 30,716 | +0.6% | 0.05% | -35.2% |
| Q2 2019 | $3,673,000 | +500.2% | 30,523 | +264.6% | 0.07% | +317.6% |
| Q1 2018 | $612,000 | -90.2% | 8,371 | -92.2% | 0.02% | -90.6% |
| Q4 2017 | $6,257,000 | – | 107,724 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |